Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities
[Abstract] Acta Biochim Biophys Sin (Shanghai)
The weight gain associated with IcoSema treatment in this trial is modest, suggesting that the semaglutide component of IcoSema mitigated the weight gain normally expected with insulin initiation [18]
Read on to learn more about the compound and its functions and benefits
Para quienes, pese a las advertencias, decidan informarse sobre su uso, la reduccin de riesgos pasa por medidas bsicas de sentido comn: consultar previamente a un profesional sanitario, priorizar proveedores que aporten certificados de anlisis de terceros, respetar condiciones estrictas de esterilidad, no compartir material de inyeccin y no combinar con otras sustancias sin supervisin